Low-dose, short-acting, angiotensin-converting enzyme inhibitors as rescue therapy in pregnancy

Obstetrics and Gynecology

Volumn 97, Issue 5, 2001, Pages 799-

  Pryde, Peter G ^a   Barr, Mason ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADOLESCENT; ADOLESCENT PREGNANCY; DOSE RESPONSE; FEMALE; HIGH RISK PREGNANCY; HUMAN; NOTE; PREGNANCY; PREGNANCY COMPLICATION; PREMATURE LABOR; RISK FACTOR; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; OBSTETRIC LABOR, PREMATURE; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY IN ADOLESCENCE; PREGNANCY, HIGH-RISK; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 0035349949     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/00006250-200105000-00031     Document Type: Letter

References (3)

1. Chisolm CA, Chescheir NC, Kennedy M. Reversible oligohydramnios in a pregnancy with angiotensin converting enzyme inhibitor exposure. Am J Perinatal 1997;14:511-3.
2. Barr M. Teratogen update: Angiotensin converting enzyme inhibitors. Teratology 1994;50:399-409.
3. Pryde PG, Sedman AB, Nugent CE, Barr M. Angiotensin-converting enzyme inhibitor fetopathy. J Am Soc Nephrol 1993;3:1575-82.